Sabra (SBRA) delivered FFO and revenue surprises of 0% and 0.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street ...

In a report released today, Aaron Hecht from JMP Securities reiterated a Buy rating on Sabra Healthcare REIT (SBRA – Research Report), with a ...

Sabra Health Care REIT, Inc. ( NASDAQ: SBRA) Q4 2024 Earnings Conference Call February 20, 2025 1:00 PM ET Lukas Hartwich - EVP, Finance Rick Matros - CEO, President & Chair Talya Nevo-Hacohen - CIO, ...

Truist Financial analyst Michael Lewis maintained a Hold rating on Sabra Healthcare REIT (SBRA – Research Report) today. The company’s shares ...

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.33 per share a year ago.

Sabra Healthcare (SBRA) reported $182.35 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 11.6%. EPS of $0.36 for the same period compares to $0.07 ...

New York State Teachers Retirement System raised its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 2.3% during the fourth quarter, HoldingsChannel.com reports. The institutional ...